Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Holdings
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Inv. presentation
Acq. announced
Director departure
Appointed director
Quarterly results
CC transcript

MEDIVATION, INC. (MDVN) Create: Alert

All | News | Filings
Date FiledTypeDescription
04/08/2011 MW Medivation to Host Conference Call at 8:30 a.m. Eastern Time Monday, April 11 to Discuss Phase 3 Trial Results for Dimebon in Huntington Disease
03/31/2011 MW Medivation Announces Participation in Leerink Swann Cancer Roundtable Conference
03/30/2011 MW Medivation and Astellas Announce Initiation of Phase 2 Clinical Trial Comparing MDV3100 With Bicalutamide in Advanced Prostate Cancer
03/16/2011 MW Medivation Reports Fourth Quarter and Year-End 2010 Financial Results and Provides Corporate Update
03/09/2011 MW Medivation Announces Fourth Quarter and Year-End 2010 Financial Results Teleconference and Webcast on March, 16 2011
02/15/2011 MW Medivation and Astellas Announce Positive New, Long-Term Follow-Up Data From Phase 1-2 Trial of MDV3100 in Advanced Prostate Cancer Patients
02/14/2011 MW Medivation and Astellas Announce Upcoming Presentation of New, Long-Term Follow-Up Data From Phase 1-2 Trial of MDV3100 in Advanced Prostate Cancer Patients
03/23/2010 MW INVESTOR NOTICE: The Rosen Law Firm Announces Filing of Securities Class Action Against Medivation, Inc. -- MDVN
03/12/2010 MW Brower Piven Encourages Investors Who Have Losses in Excess of $250,000 From Investment in Medivation, Inc. to Inquire About the Lead Plaintiff Position in Securities Fraud Class Action Lawsuit Before the May 10, 2010 Lead Plaintiff Deadline
03/09/2010 MW Izard Nobel LLP Announces Class Action Lawsuit Against Medivation, Inc.
03/09/2010 MW Izard Nobel LLP Announces Class Action Lawsuit Against Medivation, Inc.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy